HORIBA Instruments Inc. 5390012941 Pointe HbA1c Hemolysis Rgt Blood
The HORIBA Instruments, Inc. 5390012941 Pointe HbA1c Hemolysis Rgt is a specialized reagent designed for use in clinical settings, such as hospitals, laboratories, and outpatient clinics, where accurate blood sample analysis is crucial. This product stands out for its role in hemolysis testing, a critical process in diagnosing and managing diabetes through the measurement of HbA1c levels in blood samples.
The Pointe HbA1c Hemolysis Rgt is part of a comprehensive system for analyzing blood samples, focusing on the hemolysis aspect which is essential for precise HbA1c measurement. HbA1c, or glycated hemoglobin, is a form of hemoglobin that is bound to glucose, and its levels are a key indicator of blood glucose control over time. The reagent is used in conjunction with specific analyzers to ensure that blood samples are properly treated for accurate test results, contributing to the diagnosis, treatment, and management of diabetes.
Key Features
- Designed for use with specific HORIBA analyzers to ensure compatibility and accuracy
- Enhances the precision of HbA1c measurements through controlled hemolysis of blood samples
- Contributes to the early detection and management of diabetes by providing reliable glycemic control data
- Facilitates standardized testing procedures, ensuring consistency across different samples and operators
- Supports healthcare professionals in making informed decisions regarding patient care and treatment plans
- Manufactured with high-quality materials to minimize the risk of errors or contamination
- Available in a 500 ml volume, suitable for high-volume testing environments
Product Specifications
• Dimensions: Not specified • Weight: Not specified • Materials: High-quality reagent materials • Compliance: Designed for use with specific HORIBA analyzers, ensuring compatibility and adherence to standard testing protocolsIdeal For
• Hospitals and their laboratories • Outpatient clinics and diabetes management centers • Clinical research facilities focusing on diabetes and glycemic control • Point-of-care settings where rapid and accurate blood glucose control measurements are necessary • Home care environments equipped with compatible analyzers, under the supervision of healthcare professionalsShare Product Link: